Showing results (21-30 of 490) with videos related to
Sort By:
Pageof 49
New Zealand Veterinary Journal|May 1, 1985
Wastage and disease in Bay of Plenty dairy herdsD C AndersonAdvances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|October 25, 2000
Changes in lipid profiles in non diabetic, non nephrotic patients commencing continuous ambulatory peritoneal dialysisE O'Riordan, D J O'Donoghue, P A Kalra, et al.Acta Paediatrica (Oslo, Norway : 1992). Supplement|May 18, 2005
Is globotriaosylceramide a useful biomarker in Fabry disease?E Young, K Mills, P Morris, et al.British Medical Journal (Clinical Research Ed.)|January 7, 1984
Impact of continuous ambulatory peritoneal dialysis on treatment of renal failure in patients aged over 60A J Nicholls, S Waldek, M M Platts, et al.Lancet (London, England)|November 4, 1998
Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failureP MacDowall, P A Kalra, D J O'Donoghue, et al.Journal of Inherited Metabolic Disease|February 11, 2005
Measurement of urinary CDH and CTH by tandem mass spectrometry in patients hemizygous and heterozygous for Fabry diseaseK Mills, P Morris, P Lee, et al.British Journal of Rheumatology|December 1, 1993
Transverse myelitis as the presentation of Jo-1 antibody syndrome (myositis and fibrosing alveolitis) in long-standing ulcerative colitisD W Ray, J Bridger, J Hawnaur, et al.British Journal of Nursing (Mark Allen Publishing)|June 20, 2008
Home-based infusion therapy for patients with Fabry diseaseA Cousins, P Lee, D Rorman, et al.Biochemical Pharmacology|September 5, 2013
Biomarkers in pharmacology and drug discoveryD C Anderson, Krishna KodukulaJournal of Inherited Metabolic Disease|February 12, 2014
Long-term effectiveness of enzyme replacement therapy in adults with Gaucher disease: results from the NCS-LSD cohort studyL J Anderson, W Henley, K M Wyatt, et al.Pageof 49